Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study
<b>Background/Objectives:</b> Gut microbiota is profoundly influenced by dysglycemic states, including prediabetes (preDM) and type 2 diabetes (T2D). Although short-chain fatty acids (SCFAs) may serve as proxies reflecting these microbial changes, their predictive role remains elusive. This study aimed to evaluate the association between fecal SCFA concentrations and glycemic status (preDM and T2D), using individuals with normoglycemia (NonDM) as the reference group in a Mediterranean adult population. <b>Methods:</b> This study included a total of 88 participants from the [email protected] study who were classified into three groups according to the American Diabetes Association criteria: NonDM (45%), preDM (27%), and T2D (28%), respectively. We evaluated gut microbiota populations through massive sequencing and determined SCFAs concentration using gas chromatography-mass spectrometry. Adjusted multiple logistic regression models were used to estimate associations between SCFAs and metabolic status. <b>Results</b>: The mean age of subjects with preDM and T2D was approximately 68 years, older than that of NonDM participants (about 60 years). About 50% of the subjects in the NonDM and preDM groups were female, whereas in the T2D group, females represented about 25%. The analysis revealed that only fecal acetic acid was significantly reduced in T2D compared to NonDM (<i>p</i> = 0.036) and preDM (<i>p</i> = 0.018) groups. Remarkably, fecal acetic acid was negatively associated with T2D risk when taking preDM as the reference state (OR = 0.561 [95% CI: 0.371-0.846], <i>p</i> = 0.009). Intriguingly, fecal acetic acid was identified as a significant positive predictor of preDM risk, taking the NonDM group as reference (OR = 1.422; <i>p</i> = 0.028), while propionic acid was inversely associated with preDM (OR = 0.714; <i>p</i> = 0.028). <b>Conclusions</b>: Our analysis showed that fecal acetic acid levels were associated with a reduced risk of T2D but also with an increased risk of preDM; however, the biological relevance of these findings remains uncertain.
Authors
- Susana Amézqueta (ORCID: https://orcid.org/0000-0001-8976-467X)
- Dı́dac Mauricio (ORCID: https://orcid.org/0000-0002-2868-0250)
- Josep Franch‐Nadal (ORCID: https://orcid.org/0000-0002-5175-1555)
- Josep Lluı́s Torres (ORCID: https://orcid.org/0000-0002-5072-8265)
- Esmeralda Castelblanco
- Joan Josep Vendrell (ORCID: https://orcid.org/0000-0002-6994-6115)
- Rocío Puig-Piña (ORCID: https://orcid.org/0000-0001-9184-5583)
- Sara Ramos‐Romero (ORCID: https://orcid.org/0000-0002-9293-4454)
- Marina Idalia Rojo-López (ORCID: https://orcid.org/0000-0001-6748-3156)
- Josep Julve (ORCID: https://orcid.org/0000-0002-6531-2246)
- Julia Ponomarenko (ORCID: https://orcid.org/0000-0002-1477-9444)
Institutions
- Universitat de Vic - Universitat Central de Catalunya (ES)
- Universitat Autònoma de Barcelona (ES)
- Universitat Pompeu Fabra (ES)
- Washington University in St. Louis (US)
- Hospital de Sant Pau (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Institut de Recerca Biomèdica Catalunya Sud (ES)
- Institute of Advanced Chemistry of Catalonia (ES)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
- Centre for Genomic Regulation (ES)
- Institut Químic de Sarrià (ES)
- Institut Català de la Salut (ES)
- Universitat Rovira i Virgili (ES)
- Universitat de Barcelona (ES)
- Menéndez Pelayo International University (ES)
Publication Details
- Journal
- Nutrients
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3390/nu17183003
- Citations
- 2
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Instituto de Salud Carlos III